Journal of Translational Autoimmunity (Jan 2021)
Celiac disease in the COVID-19 pandemic
Abstract
Background: The COVID-19 pandemic has had an impact on global health. Design: The impact of the COVID-19 pandemic on patients with coeliac disease was assessed in the present review. Results: The incidence of coeliac disease and the problems associated with coeliac disease increased during the COVID-19 pandemic. Adherence to the diet is crucial for the patient's health and quality of life since the only approved therapy for coeliac disease is a gluten withdrawal. Conclusions: A gluten-free diet should be promoted by the therapeutic team and implemented among these categories of patients.